(Q68769297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Reperfusion in acute myocardial infarction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

27 September 2019

main subject

1 reference

C J Lavie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

B J Gersh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

J H Chesebro

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 April 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

549-564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

27 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Myocardial consequences of reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Reperfusion therapy of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Thrombolysis in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Thrombolytic therapy: current status (1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Thrombolytic therapy: current status (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Advances in thrombolytic therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Announcement of protocol change in thrombolysis in myocardial infarction trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Clot-selective coronary thrombolysis with pro-urokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Synergism of thrombolytic agents: investigational procedures and clinical potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Molecular mechanism of action of newer thrombolytic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Insights into the pathogenesis of acute ischemic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Determinants of improved left ventricular function after thrombolytic therapy in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Paul Dudley White lecture. Balancing the benefits, risks and unknowns of thrombolytic therapy in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Mortality reduction in ISIS-2 too optimistic because of unstable angina?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Interventions that potentially limit myocardial infarct size: overview of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

The role of beta-receptor and calcium-entry-blocking agents in acute myocardial infarction in the thrombolytic era: can the results of thrombolytic reperfusion be enhanced?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

The long-term investment of coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

Surgical treatment of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960955-0

10.1016/S0025-6196(12)60955-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2332994%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference